Current and future modalities for functional renal replacement

Urologic Clinics of North America

Volumn 26, Issue 1, 1999, Pages 235-246

  Amiel, G E ^a   Atala, A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

21 AMINOSTEROID; ANTIBIOTIC AGENT; AZATHIOPRINE; BETA 2 MICROGLOBULIN; BIOMATERIAL; COLECALCIFEROL; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; CYTOKINE; DEFEROXAMINE; DIALYSIS FLUID; ERYTHROPOIETIN; FERRITIN; FREE RADICAL; GLUTATHIONE; HYDROXYL RADICAL; IRON; LIPID; MANNITOL; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; PROTEIN; RAPAMYCIN; RECOMBINANT ERYTHROPOIETIN; TACROLIMUS; UNINDEXED DRUG; UREA;

ANEMIA; CLINICAL TRIAL; FILTER; GENE TRANSFER; GRAFT REJECTION; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IRON CHELATION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MALNUTRITION; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; XENOTRANSPLANTATION;

EID: 0032966612     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(99)80019-6     Document Type: Article

References (131)

1. Clinical practice guidelines: Hemodialysis adequacy Peritoneal dialysis adequacy Am J Kidney Dis 30 suppl 2 1997 S1
2. AC Allison EM Eugui HVV Sollinger Mycopheno-late mofetil (RS-61443): Mechanisms of action and effects in transplantation Transplant Rev 7 1993 129
3. A Atala RN Schlussel AB Retik Renal cell growth in vivo after attachment to biodegradable polymer scaffolds J Urol 153 1995 4
4. RL Bacallao FA Carone Recent advances in the understanding of polycystic kidney disease Curr Opin Nephrol Hypertens 6 1997 377
5. G Bailie M Rocco M Flanigan Peritoneal Dialysis Core Indicators Study (PD-CIS): Hematocrit (Hct) and blood pressure (BP) data [abstract] Am Soc J Nephrol 8 1997 215a
6. WH Barber JA Mankin DA Laskow Long term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients Transplantation 51 1991 70
7. J Bernadini JL Holley JR Jhonston An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD) Clin Nephrol 36 1991 29
8. J Bernadini B Piraino JL Holley A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin Am J Kidney Dis 27 1996 695
9. B Bhatala R Khanna ZJ Twardowski Peritoneal access J Postgrad Med 40 1994 170
10. WE Bloembergen FK Port Epidemiological pro-spectives on infections in chronic dialysis patients Adv Ren Replace Ther 3 1996 201
11. DL Blowey BA Warady KS McFarland The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients R Khanna Advances in Peritoneal Dialysis 1994 Peritoneal Dialysis Publishers Toronto, Canada 297
12. A Bokenkamp G Offner P Hoyer Improved absorption of cyclosporine A from the microemul-sion formulation: Implications for dosage and monitoring Pediatr Nephrol 9 1995 196
13. JM Brauhgler JF Pregenzer RL Chase Novel 21-aminosteroids as potent inhibitors of iron dependent lipid peroxidation J Biol Chem 262 1987 10438
14. M Bruno C Bangis M Marangella CAPD with amino acid dialysis solution: Long term, cross-over study Kidney Int 35 1989 1189
15. WW Carley AJ Milici JA Madri Extracellular matrix specificity for the differentiation of capillary endothelial cells Exp Cell Res 178 1988 426
16. J Chang S Sehgal C Bansbach FK-506 and rapa-mycin: Novel pharmacological probes of the immune response Trends Pharmacol Sci 12 1991 218
17. JA Chazan NP Libbey MR London The clinical spectrum of renal osteodystrophy in 57 hemodialysis patients: A correlation between biochemical parameters and bone pathology findings Clin Nephrol 35 1991 78
18. YW Cho PI Teraski M Cecka Transplantation of kidneys from donors whose hearts have stopped beating N Engl J Med 338 1998 221
19. DN Churchill Efficiency and biocompatibility of membranes Y Berland V Bonomini Dialysis Membranes: Structures and Predictions 1995 Karger Basel, Switzerland
20. GE Cimochowski E Worley WE Rutherford Superiority of the internal jugular over the subclavian access for temporary dialysis Nephron 54 1990 154
21. WR Clark C Ronco Renal replacement therapy in acute renal failure: Solute removal mechanisms and dose quantification Kidney Int Suppl 66 1998 S133
22. JT Daugirdas RR Al-Kudsi TS Ing A double blind evaluation of sodium gradient hemodialysis Am J Nephrol 5 1985 163
23. TA Depner Prescribing Hemodialysis: A Guide to Urea Modeling 1991 Kluwer Academic Boston
24. SM Diamond WL Henrich Acetate dialysate versus bicarbonate dialysate: A continuing controversy Am J Kidney Dis 9 1987 3 11
25. F Dumler K Stalla R Mohini Clinical experience with short-time hemodialysis Am J Kidney Dis 19 1992 49
26. D Ellis R Shapiro M Jordan Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation Pediatr Nephrol 8 1994 93
27. RW Evans DJ Kitzman An economic analysis of kidney transplantation Surg Clin North Am 78 1998 149
28. HI Feldman S Kobrin A Wasserstein Hemodialysis vascular access morbidity J Am Soc Nephrol 7 1996 523
29. RJ Fischel WD Payne KJ Gillingham Long-term outlook for transplant recipients with one year function Transplantation 51 1991 118
30. S Fishbane E Kowalski L Imbriano The evaluation of iron status in hemodialysis patients J Am Soc Nephrol 7 1996 2654
31. S Fishbane J Maesaka Iron management in end-stage renal disease Am J Kidney Dis 29 1997 319
32. MJ Flanigan QT Khairulah VS Lim Dialysate sodium delivery can alter chronic blood pressure management Am J Kidney Dis 29 1997 383
33. J Frank G Engler-Blum HP Rodemann Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro Exp Nephrol 1 1993 26
34. LCT Fung K Elenius M Freeman Reconstitu-tion of poor EGFr-poor renal epithelial cells into tubular structures on biodegradable polymer scaffold Pediatrics 98 1996 S631 (suppl)
35. PA Gabaw WD Kaehny SP Kelleher The spectrum of rhabdomyolysis Medicine 62 1982 141
36. R Gokal S Ash G Helfrich Peritoneal catheters and exit-site practices: Toward optimum peritoneal access Perit Dial Int 13 1996 29
37. FA Gotch JA Sargent A mechanistic analysis o( the National Cooperative Dialysis Study (NCDS) Kidney Int 28 1985 526
38. J Grinyo C Groth R Pichlmayrr Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection Lancet 345 1995 1321
39. PA Grossman RW Hamilton BM Morse Nontraumatic acute renal failure N Engl J Med 291 1974 807
40. CPDS Group Canada-USA (CANUSA) multicenter study of peritoneal dialysis adequacy: Description of the study and preliminary results Adv Perit Dial 8 1992 88
41. RM Hakim Clinical implications of hemodialysis membrane biocompatibility Kidney Int 44 1993 484
42. RM Hakim RL Wingard RA Parker Effect of dialysis membrane in the treatment of patients with acute renal failure N Engl J Med 331 1994 338
43. ED Hall PA Yonkers PK Andrus Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord trauma J Neurotrauma 9 suppl 2 1992 S425
44. Health Care Financing Administration End stage renal disease program highlights [fact sheet]. Health Care Financing Administration US Department of Health and Human Services 1997 August
45. WL Henrich JM Hunt JV Nixon Increased ionized calcium and left ventricular contractility during hemodialysis N Engl J Med 310 1984 19
46. J Himmelfarb N Tolkoff Rubin P Chandran A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis J Am Soc Nephrol 9 1998 257
47. CR Hitchcock JC Kiser RL Telander Baboon renal grafts JAMA 189 1964 934
48. HD Humes DA Cieslinski S Poirtier Tissue engineering of a bioartificial hemo-filter [abstract] J Am Soc Nephrol 6 1995 492
49. ST Ilstad DH Sachs Reconstitution with syngenic plus allogenic or xenogenic bone marrow leads to specific acceptance of allografts or xenografts Nature 307 1984 168
50. C Jacobs Membrane biocompatibility in the treatment of acute renal failure: What is the evidence in 1996 Nephrol Dial Transplant 12 1997 38
51. SC Kabasakul M Clarke J Karsten Comparison of Neoral and Sandimmune cyclosporine A pharmacokinetic profiles in young renal transplant recipients Pediatr Nephrol 11 1997 318
52. BL Kasiske The evaluation of prospective renal transplant recipients and living donors Surg Clin North Am 78 1998 27
53. BL Kasiske M Ravenscraft EL Ramos The evaluation of renal transplant candidates: Clinical practice guidelines J Am Soc Nephrol 7 1996 2288
54. W Keane S Alexander G Bailie Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update Perit Dial Int 16 1996 557
55. P Kingwatanakul BA Warady Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis R Khanna Advances in Peritoneal Dialysis 1997 Peritoneal Dialysis Publications Toronto, Canada 280
56. A Levin MB Goldstein The benefits and side effects of hampered hypertonic sodium dialysis J Am Soc Nephrol 7 1996 242
57. F Locatelli G Pontoriero Di Filippo S Electrolyte disorders and substitution fluid in continuous renal replacement therapy Kidney Int Suppl 66 1998 S151
58. M Luzar G Coles B Faller Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis N Engl J Med 322 1990 505
59. T Maack Renal handling of proteins and polypeptides EE Windhager Handbook of Physiology 1992 Oxford University Press New York 2039
60. SM MacKay AJ Funke DA Buffington Tissue engineering of a bioartificial kidney ASAIO J 44 1998 179
61. M Manns MH Sigler BP Teehan Continuous renal replacement therapies: An update Am J Kidney Dis 32 1998 185
62. J Mayes JR Thistlethwaite Jr. J Stuart Re-exposure to OKT3 in renal allograft recipients Transplantation 45 1988 349
63. GV Mazariegos H Ramos R Shapiro Weaning of immunosuppression in long-term recipients of living related renal transplants: A preliminary study Transplant Proc 27 1995 207
64. AJ Milici MB Furie WW Carley The formation of fenestrations and channels by capillary endothelium in vitro Proc Natl Acad Sei USA 82 1985 6181
65. C Mistry R Gokal E Peers the Midas Study Group A randomized multicenter clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutions in SAPD Kidney Int 46 1994 496
66. C Mistry N Mallik R Gokal The advantage of glucose polymer as an osmotic agent in continuous peritoneal dialysis Proc EDTA-ERA 22 1985 415
67. C Mistry N Mallik R Gokal Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges Lancet 2 1987 178
68. PJ Morris Transplantation in the 21st century Kidney Int 51 suppl 58 1997 S51
69. Mupirocin Study Group Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal infection J Am Soc Nephrol 7 1996 2403
70. KA Nath J Bella AJ Croatt Heme protein mediated renal injury: A protective role for 21-amino steroids in vitro and in vivo Kidney Int 47 1995 592
71. National Institute of Diabetes and Digestive and Kidney Diseases: United States Renal Data System 1997 Annual Data Report In NIH, HHS 1997
72. NIH Consensus Statement: Morbidity and mortality of dialysis In NIH 1 1993 11
73. DOQI-NKF NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure 1997
74. DOQI-NKF NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy 1997
75. KD Nolfph ME Witcomb RW Shrier Mechanisms for inefficient peritoneal dialysis in acute renal failure associated with heat and exercise Ann Intern Med 71 1969 317
76. KD Nolph Peritoneal dialysis HC Gonick Current Nephrology 1996 Mosby-Year Book St. Louis 281
77. DP O'Hair RP McManus R Komorowski Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil Ann Thorac Surg 58 1994 1311
78. MD Odland Surgical technique/post-transplant surgical complications Surg Clin North Am 78 1998 55
79. S Onishi DL Andress NA Maloney Beta-2-microglobulin deposition in bone in chronic renal failure Kidney Int 39 1991 990
80. G Opelz ZV Shwartz A Engelman Long-term impact of HLA matching on kidney survival in cyclosporine treated patients Transplant Proc 23 1991 373
81. WF Owen Jr. NL Lew Y Liu The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis N Engl J Med 329 1993 1001
82. M Park O Heimburger J Bergstom Peritoneal transport during dialysis with amino-acid based solutions Perit Dial Int 13 1993 280
83. S Pastan J Bailey Dialysis therapy N Engl J Med 338 1998 1428
84. TC Pearson JC Madsen C Larsen Induction of transplantation tolerance in the adult using donor antigen and anti-CD4 monoclonal antibody Transplantation 54 1992 475
85. M Perez-Fontan T Garcia-Falcon M Rosales Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: Long-term results Am J Kidney Dis 22 1993 708
86. JL Platt JS Logan Use of transgenic animals in xenotransplantation Transplant Rev 10 1996 69
87. JA Powelson AB Cosimi Antilymphocyte globulin and monoclonal antibodies PJ Morris Transplantation: Principles and Practice 1994 WB Saunders Philadelphia 215
88. M Princeteau Greffe renale J Med Bordeaux 26 1905 549
89. Program, National Cholesterol Education, Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults Summary of the Second Report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel II) JAMA 269 1993 3015
90. JM Radovich Composition of polymer membranes for therapies of end-stage renal disease Y Berland V Bonomini Dialysis Membranes: Structure and Predictions 1995 Karger Basel, Switzerland 11
91. K Reemtsma BH McCracken JY Schlegel Renal heterotransplantation in man Ann Surg 160 1964 384
92. JP Revillard C Vincent Structure and metabolism of beta-2-microglobulin Contrib Nephrol 62 1988 44
93. MV Rocco AJ Bleyer JM Burkart Utilization of inpatient and outpatient resources for the management of hemodialysis access complications Am J Kidney Dis 28 1996 250
94. RA Rodby EF Vonesh SM Korbet Blood pressure in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitor Am J Kidney Dis 23 1994 401
95. D Saitovitch AR Bushell PJ Morris Induction of transplantation tolerance using a non-depleting anti-CD4 monoclonal antibody and donor specific transfusion before transplantation: Evidence that a critical period of time is required for the development of immunological unresponsiveness Transplant Proc 27 1995 117
96. AK Salahuden C Wang SA Bigler Synergistic renal protection by combining alkaline diuresis with lipid peroxidation inhibitors in rhabdomyolysis: Possible interactions between oxidant and non-oxi-dant mechanisms Nephrol Dial Transplant 11 1996 635
97. R Saran SM Marshall R Madsen Long-term follow-up of kidney donors: A longitudinal study Nephrol Dial Transplant 12 1997 1615
98. F Schefer K Schefer M Mikova Residual renal function in children on hemodialysis and peritoneal dialysis therapy Pediatr Nephrol 8 1994 579
99. F Schnek M Jordan C Jensen Pediatric renal transplantation under FK-506 immunosuppression J Urol 147 1991 1585
100. R Selgas J Munoz S Cigarran Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): The effect of late peritonitis Perit Dial Int 9 1989 329
101. A Sessa GM Ghiggeri AE Turco Autosomal dominant polycystic kidney disease: Clinical and genetic aspects J Nephrol 10 1997 295
102. D Shaffer AI Sahyuon PN Madras Two hundred one consecutive living-donor nephrectomies Arch Surg 133 1998 426
103. MS Slater RJ Mullins Rhabdomyolysis and myoglobinuria renal failure in trauma and surgical patients: A review J Am Coll Surg 186 1998 693
104. E Slatopolsky C Weerts S Lopez-Hiker Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis N Engl J Med 315 1986 157
105. H Sollinger Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients Transplantation 60 1995 225
106. AW Stadnyk Cytokine production by epithelial cells FASEB J 8 1994 1041
107. TE Starzl AJ Demetrius N Maruse Cell migration, chimerism and graft acceptance Lancet 339 1992 1579
108. TE Starzl TL Marchioro GN Peters Renal heterotransplantation from baboon to man: Experience with 6 cases Transplantation 2 1964 752
109. JC Stivelman JM Soucie ES Hall Dialysis survival in a large inner-city facility: A comparison to national rates J Am Soc Nephrol 6 1995 1256
110. VP Sukhatme Prospects for gene therapy in the kidney JV Bonventre D Schlondorff Molecular Nephrology: Kidney Function in Health and Disease 1995 Marcel Dekker New York
111. RG Tearle MJ Tange ZL Zannettino The alpha-l,3-galactosyltransferase knockout mouse: Implications for xenotransplantation Transplantation 61 1996 13
112. JM Thomas M Carver P Cunningham Promotion of incompatible allograft acceptance in rhesus monkeys given post-transplant antithymocyte globulin and donor bone marrow. I. In vivo parameters and immunohistologic evidence suggesting mi-crochimerism Transplantation 43 1987 332
113. ZJ Twardowski Peritoneal catheter exit-site morphology and pathology: Prevention, diagnosis and treatment of exit-site infections Perit Dial Int 16 suppl 3 1996 S1
114. ZJ Twardowski BF Prowant B Pickett Four year experience with swan neck presternal peritoneal dialysis catheter Am J Kidney Dis 27 1996 99
115. US Renal Data System The USRDS Dialysis Morbidity and Mortality Study (wave 1) USRDS 1996 Annual Data Report 1996 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD 45
116. United Network for Organ Sharing People awaiting transplants United Network for Organ Sharing, Richmond, Virginia 1996
117. USRDS 1996 Annual Data Report: US Data System: Causes of Death 1996 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD p 85
118. SUSRD The USRDS Dialysis Morbidity and Mortality Study: Wave 2 Am J Kidney Dis 30 1997 567
119. USRDS Annual Data Report Catheter-related factors and peritonitis risk in CAPD patients Am J Kidney Dis 20 1992 548
120. S Vamvakas U Banner A Heidland Cancer in end-stage renal disease: Potential factors involved Am J Nephrol 18 1998 89
121. G Vilingo A Colombo A Scalamogna Prospected randomized study of two Y devices in continuous ambulatory peritoneal dialysis (CAPD) Perit Dial Int 9 1989 165
122. B Warady SL Watkins Current advances in the therapy of chronic renal failure and end stage renal disease Semin Nephrol 18 1998 341
123. BA Warady Optimizing dialysis in pediatric patients RN Fine AR Nissenson DE Gentile Clinical Dialysis 1995 Appleton & Lange East Norwalk, CT 189
124. MH Ward Factors predictive of acute renal failure in rhabdomyolysis Arch Intern Med 148 1988 1553
125. WK Washburn D Shaffer MA Simpson Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression Transplant Proc 28 1996 1015
126. JM Wilson LK Birinyi RN Salomon Implantation of vascular grafts lined with genetically modified endothelial cells Science 244 1989 1344
127. JD Woods DH Humes Prospects for a bioartificial kidney Semin Nephrol 17 1997 381
128. J Yoo S Ashkar A Atala Creation of functional kidney structures with excretion of kidney-like fluid in vivo Pediatrics 98S 1996 605
129. G Young J Dibble S Hobson The use of an amino-acid-based CAPD fluid over 12 weeks Nephrol Dial Transplant 4 1989 285
130. RA Zagler Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress: Mechanistic and therapeutic implications J Clin Invest 90 1992 711
131. JA Zweibel SM Freeman PW Kantoff High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors Science 243 1989 220